Demethoxycurcumin Alleviates Lipopolysaccharide‐Induced Acute Lung Injury via Nrf2‐Mediated Anti‐Inflammation and Ferroptosis Inhibition
Mediators of Inflammation · 2026
DOI: 10.1155/mi/9154680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, 2026. Verfasst von Jing Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, NHC Key Laboratory of Birth Defect for Research and Prevention (Hunan Provincial Maternal and Child Health Care Hospita…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Ferroptosis, Acute Lung Injury, Diarylheptanoids. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hunan Province, Scientific Research Project of Hunan Province Chinese Medicine, Hunan Cancer Hospital Climb Plan.
Abstract (Originalsprache)
Background
Sepsis‐induced acute lung injury (SI‐ALI) represents a life‐threatening condition driven by dysregulated immune responses and redox imbalance. Demethoxycurcumin (DMC), a bioactive analog of curcumin, exhibits marked anti‐inflammatory and free radical‐scavenging capacities. Despite its potential, the precise molecular pathways through which DMC mitigates SI‐ALI pathogenesis have yet to be fully elucidated.
Methods
SI‐ALI was induced in mice through lipopolysaccharide (LPS) administration. Lung injury was assessed by histopathological analysis and measurement of wet‐to‐dry (W/D) weight ratios. Oxidative stress markers were quantified using ELISA, and inflammatory cytokine mRNA levels were analyzed by RT‐PCR. Ferroptosis‐related proteins and Nrf2 pathway activation were evaluated through Western blotting and immunofluorescence. Mitochondrial ultrastructure was examined via transmission electron microscopy (TEM). The involvement of the Nrf2 pathway was further confirmed by using the Nrf2 inhibitor ML385.
Results
DMC treatment significantly alleviated lung injury in a dose‐dependent manner, improving histopathology and reducing W/D weight ratios. It attenuated inflammation by suppressing IL‐6, TNF‐α, and IL‐1β expression and restored oxidative balance by enhancing glutathione (GSH) levels while decreasing malondialdehyde (MDA). Moreover, DMC upregulated glutathione peroxidase 4 (GPX4) and SLC7A11, downregulated cyclooxygenase‐2 (COX2) and ACSL4, reduced nonheme iron and 4‐hydroxynonenal (4‐HNE) production, and improved mitochondrial morphology, collectively demonstrating its inhibitory effects on ferroptosis. Nrf2 inhibition partially reversed these protective effects, underscoring the central role of the Nrf2 pathway in DMC’s mechanism of action.
Conclusion
DMC ameliorates SI‐ALI by mitigating inflammation and ferroptosis through Nrf2 pathway activation, suggesting a potential therapeutic strategy for SI‐ALI treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, NHC Key Laboratory of Birth Defect for Research and Prevention (Hunan Provincial Maternal and Child Health Care Hospital), Changsha, Hunan, 410008, China, hunanfy.com.
- Department of Anesthesiology, The Second Affiliated Hospital of University of South China, Hengyang, Hunan, 421001, China, usc.edu.cn.
- Department of Anesthesiology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China, csu.edu.cn.
ORCID-Profile: Jing Tang, Qiuni Zhao, Jue Liu, Chuangxin Zheng, Zhenbiao He, Ji Xiao
Förderung
- Natural Science Foundation of Hunan Province
- Scientific Research Project of Hunan Province Chinese Medicine
- Hunan Cancer Hospital Climb Plan
Zitieren
APA
Tang, J., Zhao, Q., Liu, J., Zheng, C., He, Z., & Xiao, J. (2026). Demethoxycurcumin Alleviates Lipopolysaccharide‐Induced Acute Lung Injury via Nrf2‐Mediated Anti‐Inflammation and Ferroptosis Inhibition. Mediators of Inflammation. https://doi.org/10.1155/mi/9154680
Vancouver
Tang J, Zhao Q, Liu J, Zheng C, He Z, Xiao J. Demethoxycurcumin Alleviates Lipopolysaccharide‐Induced Acute Lung Injury via Nrf2‐Mediated Anti‐Inflammation and Ferroptosis Inhibition. Mediators of Inflammation. 2026. doi:10.1155/mi/9154680
BibTeX
@article{Tang2026,
author = {Tang, Jing and Zhao, Qiuni and Liu, Jue and Zheng, Chuangxin and He, Zhenbiao and Xiao, Ji},
title = {Demethoxycurcumin Alleviates Lipopolysaccharide‐Induced Acute Lung Injury via Nrf2‐Mediated Anti‐Inflammation and Ferroptosis Inhibition},
journal = {Mediators of Inflammation},
year = {2026},
doi = {10.1155/mi/9154680}
}
EUVIMED